Mélanie DALIGAULT

Fonction : Thèsarde

Groupe : RecSan

Publications

13 documents

Thomas Jouve, Mélanie Daligault, Johan Noble, Florian Terrec, Farida Imerzoukene, et al.. Tocilizumab Evaluation in HLA-Desensitization before Kidney Transplantation as an Add-On Therapy to Apheresis: The TETRA Study. Journal of Clinical Medicine, 2023, 12 (2), pp.424. ⟨10.3390/jcm12020424⟩. ⟨inserm-05007577⟩
Thomas Jouve, Caroline Laheurte, Johan Noble, Jules Weinhard, Mélanie Daligault, et al.. Immune responses following tocilizumab therapy to desensitize HLA-sensitized kidney transplant candidates. American Journal of Transplantation, 2022, 22 (1), pp.71-84. ⟨10.1111/ajt.16709⟩. ⟨inserm-05005378⟩
Johan Noble, Antoine Metzger, Hamza Naciri Bennani, Melanie Daligault, Dominique Masson, et al.. Apheresis Efficacy and Tolerance in the Setting of HLA-Incompatible Kidney Transplantation. Journal of Clinical Medicine, 2021, 10 (6), pp.1316. ⟨10.3390/jcm10061316⟩. ⟨hal-04997119⟩

«
1
2